Monday, March 16, 2026

Novo Nordisk Slashes GLP-1 Drug Prices by Up to 50%: What This Means for Obesity Treatments in 2027

Novo Nordisk will cut prices of GLP-1 treatments in the U.S. by up to 50% from January 2027, amid rising competition and market pressures.

North Korea’s Kim Jong Un Opens Door to U.S. Talks: What Does This Mean for 2026?

Kim Jong Un signals openness to U.S. dialogue while rejecting South Korea, emphasizing that future relations depend on U.S. actions.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

Tag: U.S.

How Korea Zinc’s New Tennessee Smelter Will Revolutionize Metal Production with AI and Robotics

Korea Zinc's new U.S. smelter will advance AI and robotics, enhancing operations at Onsan while ensuring minimal technology leakage.

K-Spine Surgery: How a Korean Firm Showcased Minimally Invasive Techniques at U.S. Conference

CGBIO successfully held a symposium on minimally invasive spinal surgery, enhancing skills of over 100 global professionals through hands-on training.

Weight-Loss Drugs Could Cut Airline Fuel Bills by $580 Million—An Unexpected Win for U.S. Carriers

The obesity treatment market is growing, helping U.S. airlines save on fuel costs due to decreased passenger weight.

Unlocking the Secrets of Hugel’s 900 Million USD Revenue Goal: A Comprehensive Guide

Hugel aims for 900 billion KRW in U.S. sales by 2028, leveraging a hybrid sales model to capture significant market share.

AI Gap Shrinks to 0.3 Points as China Matches U.S. in Key Metrics

China is closing the AI gap with the U.S., with significant advancements in models and research, though the U.S. still leads in investment.

China, U.S., and South Korea Ramp Up AI Investments in a Bid for Global Dominance

As AI competition escalates, countries like South Korea must enhance investments to bridge the tech gap with leaders like China and the U.S.

Hyundai Boosts EV Safety, Produces Ioniq 9 in U.S. to Counter Tariff Pressures and Rival Kia

Hyundai will exclusively produce the Ioniq 9 SUV in the U.S. to avoid tariffs, targeting 6,500 units in South Korea.

Tesla Falls Short: South Korea EV See Massive Growth in U.S. Market

In the first half of this year, sales of EVs in the U.S. auto market showed a slight decline compared to the previous year.

Stocks Continue to Surge Due to Ongoing AI Rally, ARM 10%, Soundhound 47%

Despite a general downturn in the U.S. stock market following last week's surge, NVIDIA, the biggest beneficiary of generative AI, continues its upward trend,...

Top News

- Our Sponsors Ad -

Follow us